Cytophotometric analysis of neuronal chromatin and RNA changes in oxotremorine-treated rats.
Neuronal nucleic acid responses were examined within the rat striatum and sensorimotor cortex (layer V) following single intraperitoneal injections of the central cholinergic-muscarinic agonist oxotremorine (0.1, 0.7, or 1.0 mg/kg). After stoichiometric Feulgen and azure B staining of brain sections, scanning-integrating microdensitometry was used to quantify Feulgen-deoxyribonucleic acid levels, changes in the susceptibility of chromatin to Feulgen acid hydrolysis (F-DNA yield) and azure B-ribonucleic acid (RNA) content of neurons on an individual basis. Changes in neuronal nuclear and nucleolar volumes were also determined histometrically. Within the striatum and sensorimotor cortex, oxotremorine produced marked dose-dependent elevations in both F-DNA yield and RNA content. These metabolic increases were typically paralleled by elevations in nuclear and nucleolar volumes. The data demonstrate that the oxotremorine-induced central muscarinic activation is associated with dose-related enhancements in neuronal chromatin template activity, RNA content, and protein synthetic capacity.
Martin
L J
LJ
Doebler
J A
JA
Anthony
A
A
D000818:Animals; D002843:Chromatin / Q000187:drug effects*; D003592:Cytophotometry; D004247:DNA / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D008297:Male; D009474:Neurons / Q000032:analysis / Q000187:drug effects*; D010095:Oxotremorine / Q000494:pharmacology*; D012313:RNA / Q000032:analysis*; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects
D002843:Chromatin; D011976:Receptors, Muscarinic; D010095:Oxotremorine; D012313:RNA; D004247:DNA; D005954:Glucosephosphate Dehydrogenase